Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 405.85 Million CNY | 42.1% |
| 2022 | 285.61 Million CNY | -8.54% |
| 2021 | 312.28 Million CNY | -9.12% |
| 2020 | 343.6 Million CNY | -14.71% |
| 2019 | 402.86 Million CNY | 1385.41% |
| 2018 | 27.12 Million CNY | -78.81% |
| 2017 | 128 Million CNY | 60.0% |
| 2016 | 80 Million CNY | 166.67% |
| 2015 | 30 Million CNY | 0.0% |
| 2014 | 30 Million CNY | 5786.05% |
| 2013 | 509.68 Thousand CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 20 Million CNY | 0.0% |
| 2008 | 20 Million CNY | -50.0% |
| 2007 | 40 Million CNY | -32.55% |
| 2006 | 59.3 Million CNY | 64.72% |
| 2005 | 36 Million CNY | -59.82% |
| 2004 | 89.6 Million CNY | 20.44% |
| 2003 | 74.39 Million CNY | -24.77% |
| 2002 | 98.88 Million CNY | -23.05% |
| 2001 | 128.5 Million CNY | 15.04% |
| 2000 | 111.7 Million CNY | 45.63% |
| 1999 | 76.7 Million CNY | -46.96% |
| 1998 | 144.6 Million CNY | 34.14% |
| 1997 | 107.8 Million CNY | 35.62% |
| 1996 | 79.49 Million CNY | 25.08% |
| 1995 | 63.55 Million CNY | 6.99% |
| 1994 | 59.4 Million CNY | 25.76% |
| 1993 | 47.23 Million CNY | 32.45% |
| 1992 | 35.66 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 280.29 Million CNY | -30.94% |
| 2024 Q2 | 246.7 Million CNY | -11.98% |
| 2024 Q3 | 231.57 Million CNY | -18.86% |
| 2023 Q3 | 271.5 Million CNY | 0.46% |
| 2023 FY | 405.85 Million CNY | 42.1% |
| 2023 Q4 | 405.85 Million CNY | 49.48% |
| 2023 Q1 | 284.46 Million CNY | -0.4% |
| 2023 Q2 | 270.26 Million CNY | -4.99% |
| 2022 Q4 | 285.61 Million CNY | -0.94% |
| 2022 Q3 | 288.33 Million CNY | -1.12% |
| 2022 Q2 | 291.6 Million CNY | -5.33% |
| 2022 FY | 285.61 Million CNY | -8.54% |
| 2022 Q1 | 308.01 Million CNY | -1.37% |
| 2021 FY | 312.28 Million CNY | -9.12% |
| 2021 Q1 | 334.33 Million CNY | -2.7% |
| 2021 Q2 | 313.6 Million CNY | -6.2% |
| 2021 Q3 | 309.08 Million CNY | -1.44% |
| 2021 Q4 | 312.28 Million CNY | 1.03% |
| 2020 Q4 | 343.6 Million CNY | -10.26% |
| 2020 FY | 343.6 Million CNY | -14.71% |
| 2020 Q3 | 382.89 Million CNY | 0.84% |
| 2020 Q2 | 379.69 Million CNY | 11.72% |
| 2020 Q1 | 339.85 Million CNY | -15.64% |
| 2019 FY | 402.86 Million CNY | 1385.41% |
| 2019 Q1 | 57.12 Million CNY | 110.61% |
| 2019 Q2 | 151.55 Million CNY | 165.32% |
| 2019 Q3 | 182.8 Million CNY | 20.62% |
| 2019 Q4 | 402.86 Million CNY | 120.38% |
| 2018 Q2 | 33 Million CNY | -73.17% |
| 2018 Q3 | 9 Million CNY | -72.73% |
| 2018 Q4 | 27.12 Million CNY | 201.35% |
| 2018 FY | 27.12 Million CNY | -78.81% |
| 2018 Q1 | 123 Million CNY | -3.91% |
| 2017 Q1 | 190 Million CNY | 137.5% |
| 2017 Q4 | 128 Million CNY | -31.91% |
| 2017 Q3 | 188 Million CNY | -1.05% |
| 2017 Q2 | 190 Million CNY | 0.0% |
| 2017 FY | 128 Million CNY | 60.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q2 | 30 Million CNY | 0.0% |
| 2016 Q3 | 30 Million CNY | 0.0% |
| 2016 Q4 | 80 Million CNY | 166.67% |
| 2016 FY | 80 Million CNY | 166.67% |
| 2015 FY | 30 Million CNY | 0.0% |
| 2015 Q3 | 30 Million CNY | 0.0% |
| 2015 Q2 | 30 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q4 | 30 Million CNY | 0.0% |
| 2014 Q3 | 30.49 Million CNY | 0.0% |
| 2014 Q1 | 30.5 Million CNY | 5886.05% |
| 2014 FY | 30 Million CNY | 5786.05% |
| 2014 Q4 | 30 Million CNY | -1.62% |
| 2014 Q2 | 30.49 Million CNY | -0.05% |
| 2013 Q3 | 30.5 Million CNY | -85.71% |
| 2013 Q2 | 213.5 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 509.68 Thousand CNY | -98.33% |
| 2013 FY | 509.68 Thousand CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2010 Q1 | 20 Million CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q2 | 20 Million CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q3 | - CNY | -100.0% |
| 2009 FY | 20 Million CNY | 0.0% |
| 2009 Q3 | 20 Million CNY | 0.0% |
| 2009 Q1 | 20 Million CNY | 0.0% |
| 2009 Q4 | 20 Million CNY | 0.0% |
| 2009 Q2 | - CNY | -100.0% |
| 2008 Q3 | 20 Million CNY | 0.0% |
| 2008 Q4 | 20 Million CNY | 0.0% |
| 2008 Q1 | 30 Million CNY | -25.0% |
| 2008 Q2 | 20 Million CNY | -33.33% |
| 2008 FY | 20 Million CNY | -50.0% |
| 2007 Q2 | 40 Million CNY | 107.25% |
| 2007 Q4 | 40 Million CNY | 0.0% |
| 2007 FY | 40 Million CNY | -32.55% |
| 2007 Q1 | 19.3 Million CNY | -67.45% |
| 2007 Q3 | 40 Million CNY | 0.0% |
| 2006 FY | 59.3 Million CNY | 64.72% |
| 2006 Q4 | 59.3 Million CNY | -7.11% |
| 2006 Q2 | 63.84 Million CNY | -16.0% |
| 2006 Q3 | 63.84 Million CNY | 0.0% |
| 2006 Q1 | 76 Million CNY | 111.11% |
| 2005 Q3 | 86.5 Million CNY | -1.14% |
| 2005 FY | 36 Million CNY | -59.82% |
| 2005 Q4 | 36 Million CNY | -58.38% |
| 2005 Q2 | 87.5 Million CNY | -2.34% |
| 2005 Q1 | 89.6 Million CNY | 0.0% |
| 2004 FY | 89.6 Million CNY | 20.44% |
| 2004 Q4 | 89.6 Million CNY | 115.38% |
| 2004 Q2 | 56.63 Million CNY | -21.12% |
| 2004 Q1 | 71.79 Million CNY | -3.49% |
| 2004 Q3 | 41.6 Million CNY | -26.55% |
| 2003 Q4 | 74.39 Million CNY | -8.15% |
| 2003 Q1 | 98.29 Million CNY | -0.6% |
| 2003 Q2 | 92.29 Million CNY | -6.11% |
| 2003 FY | 74.39 Million CNY | -24.77% |
| 2003 Q3 | 80.99 Million CNY | -12.24% |
| 2002 Q4 | 98.88 Million CNY | -4.46% |
| 2002 FY | 98.88 Million CNY | -23.05% |
| 2002 Q1 | 128.5 Million CNY | 0.0% |
| 2002 Q2 | 103.5 Million CNY | -19.46% |
| 2002 Q3 | 103.5 Million CNY | 0.0% |
| 2001 Q2 | 128 Million CNY | 0.0% |
| 2001 FY | 128.5 Million CNY | 15.04% |
| 2001 Q4 | 128.5 Million CNY | 0.0% |
| 2000 Q4 | 111.7 Million CNY | 0.0% |
| 2000 FY | 111.7 Million CNY | 45.63% |
| 2000 Q2 | 72.7 Million CNY | 0.0% |
| 1999 Q4 | 76.7 Million CNY | 0.0% |
| 1999 Q2 | 42.35 Million CNY | 0.0% |
| 1999 FY | 76.7 Million CNY | -46.96% |
| 1998 FY | 144.6 Million CNY | 34.14% |
| 1998 Q4 | 144.6 Million CNY | 0.0% |
| 1998 Q2 | 134.68 Million CNY | 0.0% |
| 1997 Q4 | 107.8 Million CNY | 0.0% |
| 1997 FY | 107.8 Million CNY | 35.62% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 FY | 79.49 Million CNY | 25.08% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 79.49 Million CNY | 0.0% |
| 1995 Q4 | 63.55 Million CNY | 0.0% |
| 1995 FY | 63.55 Million CNY | 6.99% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | 59.4 Million CNY | 25.76% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 Q4 | 59.4 Million CNY | 0.0% |
| 1993 Q2 | 36.65 Million CNY | 0.0% |
| 1993 FY | 47.23 Million CNY | 32.45% |
| 1993 Q4 | 47.23 Million CNY | 0.0% |
| 1992 FY | 35.66 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | -439.864% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.33 Billion CNY | 69.549% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | 60.829% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -1258.767% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 114.76 Million CNY | -253.632% |
| NanJing Pharmaceutical Company Limited | 11.61 Billion CNY | 96.506% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 291.35 Million CNY | -39.295% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 150 Million CNY | -170.567% |